Clinical Trial Update: Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss [Phase 3]

View source ↗

Summary

A phase 3 randomized, blinded trial comparing raloxifene, lasofoxifene, and placebo on bone loss in osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Evista (raloxifene)
• Lasofoxifene (Lasofoxifene)

Snippet

Sponsor: Ligand Pharmaceuticals | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED